Journal of Virology, October 1999, p. 8817-8823, Vol. 73, No. 10
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Department of Neuropharmacology, The Scripps Research Institute, La Jolla, California 92037,1 and The National Center for Microscopy and Imaging Research, University of California at San Diego, La Jolla, California 920932
Received 21 May 1999/Accepted 6 July 1999
A human recombinant monoclonal antibody to herpes simplex virus
(HSV) glycoprotein D labeled with the fluorescent dye Cy5 was
administered to mice infected in the cornea with HSV type 1 (HSV-1).
The distribution of such antibody in the corneas and trigeminal ganglia
of the mice was then investigated by confocal microscopy. The antibody
was detected on HSV-infected nerve fibers in the cornea
identified by
colocalization with HSV antigens and the neuritic markers
neurofilament, GAP-43, synapsin-1, and CNPase
and on the perikarya of
sensory neurons in the HSV-1-infected neurons in ipsilateral trigeminal
ganglia. Antibodies have been shown to be effective against many
neurotropic viruses, often in the absence of obvious cell damage.
Observations from experimental HSV infections suggest that antibodies
could act in part by interfering with virus expression in the ganglia
and/or with axonal spread. The present results provide morphological
evidence of the localization of antiviral antibodies at anatomical
sites relevant to such putative antibody-mediated protective actions
and suggest that viral glycoproteins are accessible to antibodies on
infected nerve fibers and sensory neurons.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|